Human papillomavirus (HPV) testing for normal cervical cytology in low-risk women aged 30-65 years by family physicians
- PMID: 24204068
- PMCID: PMC4762362
- DOI: 10.3122/jabfm.2013.06.120260
Human papillomavirus (HPV) testing for normal cervical cytology in low-risk women aged 30-65 years by family physicians
Abstract
Purpose: The purpose of this study was to assess ordering of human papillomavirus (HPV) testing for normal cervical cytology among low-risk women aged 30 to 65 years.
Methods: Audits of 833 cytology request forms for low-risk women completing a Papanicolaou smear, from January 2008 to April 2011, from 5 Michigan family medicine clinics determined HPV orders completed by the clinician performing the Papanicolaou smear. Multivariate logistic regression models examined differences in HPV test ordering by patient age at Papanicolaou test, provider status and sex, and clinic across sites. A Poisson regression model analyzed the annual number of HPV test orders over time.
Results: Cytology requests were completed by 622 faculty (75%), 169 residents/fellows (20%), and 42 nurse practitioner/physician assistants (NP/PAs) (5%). HPV testing for any cytology result was ordered on 324 request forms (39%) by residents/fellows (48%), faculty (38%), and NP/PAs (10%). Female providers were twice as likely as men to order HPV testing for any cytology result across all clinics and provider statuses (P < .001). There were significant differences in HPV test ordering among clinics. Between 2008 and 2011 annual cytology requests increased 46%, including HPV testing for any cytology result after adjusting for faculty provider sex.
Conclusion: HPV test ordering when cytology is collected varied by clinic and provider status and sex. HPV co-testing for any cytology result remains modest, but is increasing over time in these clinics.
Keywords: Diagnostic Use; Human Papilloma Virus DNA Probes; Mass Screening; Vaginal Smears.
Conflict of interest statement
Figures
Similar articles
-
Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?Cancer Epidemiol. 2009 Dec;33(6):446-50. doi: 10.1016/j.canep.2009.10.013. Epub 2009 Nov 20. Cancer Epidemiol. 2009. PMID: 19931499 Free PMC article.
-
HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.JAMA. 2000 Jan 5;283(1):81-6. doi: 10.1001/jama.283.1.81. JAMA. 2000. PMID: 10632284
-
Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.Salud Publica Mex. 2002 Jul-Aug;44(4):335-44. doi: 10.1590/s0036-36342002000400007. Salud Publica Mex. 2002. PMID: 12216521
-
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33. Epidemiol Prev. 2012. PMID: 23139163 Review. Italian.
-
Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents.J Adolesc Health. 2008 Oct;43(4 Suppl):S41-51. doi: 10.1016/j.jadohealth.2008.04.007. Epub 2008 Jul 23. J Adolesc Health. 2008. PMID: 18809144 Free PMC article. Review.
Cited by
-
Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and underinsured women.BMC Womens Health. 2018 Oct 3;18(1):162. doi: 10.1186/s12905-018-0656-3. BMC Womens Health. 2018. PMID: 30285820 Free PMC article.
References
-
- US Food and Drug Adminstration. Digene Hybrid Capture 2 High-Risk HPV DNA TEstP890064 Soo9 A004. 2012 Jun 4; http://www.accessdata.fda.gov/cdrh_docs/pdf/p890064s009a.pdf1.
-
- Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137:516–42. - PubMed
-
- Moyer VA. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156:880–91. W312. - PubMed
-
- Noller KL, Bettes B, Zinberg S, Schulkin J. Cervical cytology screening practices among obstetrician-gynecologists. Obstet Gynecol. 2003;102:259–65. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous